D. Šálek

11.9k total citations
5 papers, 91 citations indexed

About

D. Šálek is a scholar working on Pathology and Forensic Medicine, Neurology and Genetics. According to data from OpenAlex, D. Šálek has authored 5 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 1 paper in Genetics. Recurrent topics in D. Šálek's work include Lymphoma Diagnosis and Treatment (5 papers), CNS Lymphoma Diagnosis and Treatment (3 papers) and Chronic Lymphocytic Leukemia Research (1 paper). D. Šálek is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), CNS Lymphoma Diagnosis and Treatment (3 papers) and Chronic Lymphocytic Leukemia Research (1 paper). D. Šálek collaborates with scholars based in Czechia, Australia and Poland. D. Šálek's co-authors include Heidi Móciková, Lukáš Smolej, Michael E. Williams, Hanneke C. Kluin‐Nelemans, Katarzyna Krawczyk, John F. Seymour, Jan Walewski, Luca Arcaini, Anupkumar George and Eva Giné and has published in prestigious journals such as Annals of Oncology, Hematological Oncology and PubMed.

In The Last Decade

D. Šálek

4 papers receiving 90 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Šálek Czechia 2 82 55 52 35 13 5 91
Katarzyna Domańska‐Czyż Poland 3 77 0.9× 36 0.7× 55 1.1× 19 0.5× 7 0.5× 12 89
Kathrin Aprile von Hohenstaufen Switzerland 3 109 1.3× 40 0.7× 78 1.5× 43 1.2× 16 1.2× 4 125
Sandra Le Guyader-Peyrou France 3 56 0.7× 33 0.6× 40 0.8× 10 0.3× 11 0.8× 6 78
G. Marcacci Italy 4 56 0.7× 25 0.5× 39 0.8× 37 1.1× 9 0.7× 10 90
Adolfo de la Fuente Spain 6 44 0.5× 31 0.6× 19 0.4× 37 1.1× 18 1.4× 20 102
Kara Higgins United States 4 90 1.1× 102 1.9× 33 0.6× 14 0.4× 11 0.8× 7 119
H. Ghesquières France 3 99 1.2× 41 0.7× 43 0.8× 90 2.6× 8 0.6× 6 106
Barron C. Fishburne United States 2 111 1.4× 47 0.9× 56 1.1× 127 3.6× 10 0.8× 2 164
Gavin Preston United Kingdom 5 36 0.4× 28 0.5× 17 0.3× 26 0.7× 8 0.6× 10 72
Pegah Farrokhi Iran 4 40 0.5× 27 0.5× 22 0.4× 9 0.3× 17 1.3× 6 63

Countries citing papers authored by D. Šálek

Since Specialization
Citations

This map shows the geographic impact of D. Šálek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Šálek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Šálek more than expected).

Fields of papers citing papers by D. Šálek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Šálek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Šálek. The network helps show where D. Šálek may publish in the future.

Co-authorship network of co-authors of D. Šálek

This figure shows the co-authorship network connecting the top 25 collaborators of D. Šálek. A scholar is included among the top collaborators of D. Šálek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Šálek. D. Šálek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Belada, David, Heidi Móciková, Aleš Obr, et al.. (2025). 647 | SAFETY AND EFFICACY OF GLOFITAMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA ‐DATA FROM REAL‐WORLD STUDY. Hematological Oncology. 43(S3). 1 indexed citations
2.
3.
Obr, Aleš, Pavel Klener, David Belada, et al.. (2017). MAINTENANCE RITUXIMAB IMPROVES SURVIVAL IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP. Hematological Oncology. 35(S2). 205–206. 1 indexed citations
4.
Cheah, Chan Y., Anupkumar George, Eva Giné, et al.. (2013). Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Annals of Oncology. 24(8). 2119–2123. 83 indexed citations
5.
Belada, David, Lukáš Smolej, Robert Pytlík, et al.. (2010). [Staging of non-Hodgkin's lymphoma--recommendations of the Czech Lymphoma Study Group].. PubMed. 23(3). 146–54. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Domańska‐Czyż Breakdown of academic impact, for papers by Kathrin Aprile von Hohenstaufen Breakdown of academic impact, for papers by Sandra Le Guyader-Peyrou Breakdown of academic impact, for papers by G. Marcacci Breakdown of academic impact, for papers by Adolfo de la Fuente Breakdown of academic impact, for papers by Kara Higgins Breakdown of academic impact, for papers by H. Ghesquières Breakdown of academic impact, for papers by Barron C. Fishburne Breakdown of academic impact, for papers by Gavin Preston Breakdown of academic impact, for papers by Pegah Farrokhi
Rankless by CCL
2026